Page last updated: 2024-08-25

oxazolidin-2-one and Tuberculosis, Drug-Resistant

oxazolidin-2-one has been researched along with Tuberculosis, Drug-Resistant in 99 studies

Research

Studies (99)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	24 (24.24)	29.6817
2010's	65 (65.66)	24.3611
2020's	10 (10.10)	2.80

Authors

Authors	Studies
Deng, G; Fu, L; Wang, Y; Yang, M; Zhan, S; Zhang, P	1
Aono, A; Chikamatsu, K; Hosoya, M; Igarashi, Y; Mitarai, S; Morishige, Y; Murase, Y; Osugi, A; Shimomura, Y; Takaki, A; Yamada, H	1
Lu, H; Wang, H; Zhang, D; Zhao, H	1
Betoudji, F; Converse, PJ; Fotouhi, N; Lee, J; Li, SY; Mdluli, K; Nuermberger, EL; Upton, A	1
Cooper, CB; Denny, WA; Ding, CZ; Ding, J; He, S; Lu, Y; Lynch, AS; Ma, Z; Upton, AM; Wan, D; Wang, X; Yuan, Y; Zhang, Q; Zhuang, Z	1
Fu, L; Huang, H; Li, G; Li, Y; Liu, Y; Lu, H; Lu, Y; Ma, C; Sheng, L; Wang, B; Zhang, B; Zhang, D; Zhao, H	1
Becker, P; Keddy, KH; Lancaster, J; Shean, K; van der Walt, ML	1
Centner, CM; Chirehwa, M; Court, R; de Vries, N; Denti, P; Gumbo, T; Harding, J; Maartens, G; McIlleron, H; Wiesner, L	1
Fatmawati, U; Pratama, NYI; Zulkarnain, BS	1
Karkara, BB; Kumar, A; Panda, G	1
Antonova, OV; Arslanbaeva, LR; Borisov, SE; Gryadunov, DA; Isakova, AI; Krylova, LY; Kulagina, EV; Makarova, MV; Nosova, EY; Peretokina, IV; Safonova, SG; Zimenkov, DV	1
Alffenaar, JWC; Migliori, GB; Peloquin, CA	1
Court, R; de Vries, N; Gumbo, T; Harding, J; Maartens, G; McIlleron, H; Stewart, A; Wiesner, L	1
Bujalska-Zadrozny, M; Pstragowski, M; Zbrzezna, M	1
Boulle, A; Fox, T; Khomo, N; Kock, Y; Leslie, J; Manning, K; Meintjes, G; Mudaly, V; Stewart, A; Tiffin, N; Wasserman, S; Zhao, Y	1
Nair, SG; Patel, DB; Patel, HD; Rathwa, SK; Vasava, MS	1
Ahmed, I; Hasan, R; Inayat, R; Jabeen, K	1
Alffenaar, JW; Bolhuis, MS; de Lange, WC; Kosterink, JG; Uges, DR; van Altena, R; van der Werf, TS; van Soolingen, D	1
Davis, JG; Farley, J; Lancaster, J; Odendaal, R; Shean, K; Van der Walt, M	1
Chan, RC; Chang, KC; Chau, CH; Cheung, SW; Leung, CC; Tam, CM; Wen, PK; Yew, WW	1
Alffenaar, JW; Bolhuis, MS; de Lange, WC; Greijdanus, B; Kosterink, JG; Uges, DR; van Altena, R; van der Werf, TS; van Hateren, K	1
Hwang, TJ; Jafarov, A; Jakubowiak, W; Keshavjee, S; Nunn, P; Wares, DF	1
Chang, KC; Leung, CC; Tam, CM; Yew, WW	1
Centis, R; D'Ambrosio, L; Migliori, GB; Sotgiu, G; Spanevello, A	1
Arias Moya, MÁ; Bécares Martínez, FJ; Bonilla Porras, M; Castillo Bazán, E; Gómez Pérez, M; Hernández Segurado, M; Panadero Esteban, MI; Toledano Mayoral, G	1
Kim, DS; Kim, WS; Lee, SD; Lyu, J; Shim, TS; Yoo, JW	1
Chu, NH; Nie, WJ	1
Fu, L; Guo, Z; Li, P; Liu, S; Wang, B; Zhang, J; Zhao, W; Zheng, M	1
Migliori, GB; Peloquin, CA; Sotgiu, G; Srivastava, S	1
Chuchottaworn, C; Roongruangpitayakul, C	1
Conradie, F; Evans, D; Louw, R; Mabaso, S; Mabiletsa, T; Sefoka, M; Van Rie, A	1
Garcia-Prats, AJ; Hesseling, AC; Rose, PC; Schaaf, HS	1
Addison, P; Agrawal, R; Pavesio, C; Pefkianaki, M; Saihan, Z	1
Liu, C; Pang, Y; Wang, Y; Zhang, Z; Zhao, Y	1
Jeong, BH; Koh, WJ; Kwon, YS	1
Brito, M; Correia, P; Rodrigues, M; Villar, M	1
Alffenaar, JW; Bolhuis, MS; Kosterink, JG; van der Laan, T; van der Werf, TS; van Soolingen, D	1
Lange, C; Yew, WW	1
Chaiprasert, A; Charoensook, S; Leechawengwongs, M; Makhao, N; Prammananan, T; Sirirudeeporn, P; Srimuang, S; Theankeaw, O; Tingtoy, N; Tomnongdee, N	1
Chang, KC; Heyckendorf, J; Lange, C; Olaru, ID; von Groote-Bidlingmaier, F; Yew, WW	1
Bauer, TT; Bettermann, G; Bös, L; Mauch, H; Otto-Knapp, R; Rüssmann, H; Schönfeld, N; Weiss, T	1
Castiglia, P; Centis, R; D'Ambrosio, L; Migliori, GB; Sotgiu, G	1
Liu, H; Liu, N; Wang, Y; Zhao, L	1
Cesur, S; Şimşek, H; Tarhan, G	1
Feizabadi, MM; Gizaw Feyisa, S; Haeili, M; Hashemi Shahraki, A; Imani Fooladi, AA; Kardan Yamchi, J; Kazemian, H; Mohajeri, P; Rezaei, F; Zahednamazi, F; Zaker Bostanabd, S	1
Bateman, C	1
Butler-Laporte, G; Menzies, D; Winters, N	1
Santin, M	1
Benson, CA; Maartens, G	1
Berry, C; du Cros, P; Phillips, PP; Seddon, JA; Yates, TA	1
Ahuja, S; Benedetti, A; Cox, H; Fox, GJ; Koh, WJ; Menzies, D; Pasvol, G; Viiklepp, P	1
Condos, R; Hadgiangelis, N; Harkin, T; Jacquette, G; Leibert, E; Rom, WN	1
Cho, SN; Koh, WJ; Kwon, OJ; Nam, HS; Shim, TS	1
Chaiprasert, A; Leechawengwongs, M; Prammananan, T	1
Centis, R; Eker, B; Hoffmann, H; Kirsten, D; Lange, C; Migliori, GB; Muetterlein, R; Ortmann, J; Ruesch-Gerdes, S; Schaberg, T; Sotgiu, G	1
Nau, JY	1
Leung, CC; Yew, WW	1
Besozzi, G; Bevilacqua, N; Centis, R; Eker, B; Girardi, E; Hoffmann, H; Kirsten, D; Lange, C; Migliori, GB; Ortmann, J; Richardson, MD; Skrahina, A; Sotgiu, G; Zellweger, JP	1
Kirtaeva, OV; Lazareva, IaR; Romanova, EV; Sokolova, GB; Tsybane, AA	1
Cho, SN; Chung, JW; Gwak, H; Kim, WS; Koh, WJ; Kwon, OJ; Shim, TS	1
Bilgin, K; Coban, AY; Durupinar, B; Uzun, M	1
Centis, R; Eker, B; Guenther, G; Lange, C; Matteelli, A; Migliori, GB; Richardson, MD; Sotgiu, G; Spanevello, A	1
Chang, KC; Chau, CH; Yew, WW	2
Koh, WJ; Shim, TS	1
Boutoille, D; Depatureaux, A; Grossi, O; Tattevin, P	1
Flood, J; Mase, S; Raftery, A; Schecter, GF; Scott, C; True, L	1
Alffenaar, JW; Kosterink, JG; Proost, JH; Uges, DR; van Altena, R; van der Werf, TS	1
Ahuja, SD; Anger, HA; Dworkin, F; Munsiff, SS; Nilsen, DM; Sharma, S	1
Calza, L; Dal Monte, P; Manfredi, R; Nanetti, A	1
Alffenaar, JW; Filguera, P; Harmelink, IM; Kosterink, JG; Molenaar, E; Uges, DR; van Altena, R; van der Werf, TS; van Soolingen, D; Wessels, AM	1
Bertaina, C; Bignamini, E; Cordola, G; Esposito, I; Mignone, F; Milano, R; Pinon, M; Scolfaro, C; Tovo, PA	1
Vora, A	1
Alffenaar, JW; de Neeling, H; Simons, S; van de Kasteele, PJ; van der Laan, T; van der Werf, TS; van Soolingen, D	1
Cremades, R; Galiana, A; Garcia-Pachón, E; López, P; Rodríguez, JC; Royo, G; Ruiz-García, M	1
Cox, H; Ford, N	1
Andries, K; Bantubani, N; De Marez, T; Diacon, AH; Donald, PR; Grobusch, M; Lounis, N; Mahanyele, R; McNeeley, DF; Meyvisch, P; Narasimooloo, R; Patientia, RF; Pym, A; van Heeswijk, R	1
Jeon, K; Kang, YR; Kim, WS; Koh, WJ; Kwon, OJ; Lyu, J; Shim, TS	1
Amoabeng, O; Andries, K; Mdluli, KE; Minkowski, A; Nuermberger, EL; Peloquin, CA; Taylor, D; Wallis, RS; Williams, K	1
Alffenaar, JW; Anger, HA; Caminero, JA; Castiglia, P; Centis, R; D'Ambrosio, L; De Lorenzo, S; Ferrara, G; Koh, WJ; Migliori, GB; Schecter, GF; Shim, TS; Singla, R; Skrahina, A; Sotgiu, G; Spanevello, A; Udwadia, ZF; Villar, M; Zampogna, E; Zellweger, JP; Zumla, A	1
Alffenaar, JW; Bolhuis, MS; van Altena, R	1
Dong, M; He, J; Jiang, Y; Lei, H; Meng, X; Tong, A; Wang, D; Yang, C; Zhu, L	1
Jiang, RH; Li, L; Xiao, HP; Xu, HB	1
Chang, KC; Daley, CL; Leung, CC	2
Alffenaar, JW; Bolhuis, MS; Brouwers, JR; de Lange, WC; Greijdanus, B; Koster, RA; Uges, DR; van Altena, R; Vu, DH	1
Alffenaar, JW; Bolhuis, MS; Centis, R; D'Ambrosio, L; De Lorenzo, S; Migliori, GB; Piana, A; Sotgiu, G; Spanevello, A; Tiberi, S; van Altena, R; Viggiani, P	1
Hallbauer, UM; Hesseling, AC; Rose, PC; Schaaf, HS; Seddon, JA	1
Nunn, A	1
El-Sadr, WM; Feng, PJ; Heilig, CM; Hirsch-Moverman, Y; Mac Kenzie, WR; Padayatchi, N; Saukkonen, J; Villarino, E; Weiner, M	1
Cox, H; Ford, N; Goemaere, E; Hughes, J	1
Alcalá, L; Bouza, E; Díaz-Infantes, M; García De Viedma, D; Marín-Arriaza, M; Pérez-Fernández Turégano, C; Ruiz-Serrano, MJ	1
Brubakk, O; Sandven, P; von der Lippe, B	1
Cobo, J; De la Pedrosa, EG; Fortún, J; Gómez-Mampaso, E; Martín-Dávila, P; Moreno, S; Navas, E; Pérez-Elías, MJ; Tato, M	1
Climent Grana, E; Fernández Aracil, C; Hernández Prats, C; Llinares Tello, F	1
Hillemann, D; Richter, E; Rüsch-Gerdes, S	1
Chau, CH; Wen, KH; Yew, WW	1
Chen, BC; Chen, YS; Huang, TS; Liu, YC; Sy, CL; Tu, HZ	1
González-Lahoz, JM; Laguna, F; Moreno, V; Valencia, ME	1

Reviews

14 review(s) available for oxazolidin-2-one and Tuberculosis, Drug-Resistant

Article	Year
Recent advances in oxazolidinones as antituberculosis agents. Future medicinal chemistry, 2022, Volume: 14, Issue:15 Topics: Antitubercular Agents; Humans; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis; Tuberculosis, Multidrug-Resistant	2022
Novel candidates in the clinical development pipeline for TB drug development and their synthetic approaches. Chemical biology & drug design, 2021, Volume: 98, Issue:5 Topics: Adamantane; Animals; Antitubercular Agents; DNA Gyrase; Drug Development; Enzyme Inhibitors; Humans; Isonicotinic Acids; Mycobacterium tuberculosis; Oxazolidinones; Piperidines; Pyrroles; Structure-Activity Relationship; Tuberculosis; Tuberculosis, Multidrug-Resistant; Uridine	2021
ADVANCES IN PHARMACOTHERAPY OF TUBERCULOSIS. Acta poloniae pharmaceutica, 2017, Volume: 74, Issue:1 Topics: Antitubercular Agents; Clinical Trials as Topic; Diarylquinolines; Humans; Nitroimidazoles; Oxazolidinones; Tuberculosis, Multidrug-Resistant	2017
Development of new drug-regimens against multidrug-resistant tuberculosis. The Indian journal of tuberculosis, 2019, Volume: 66, Issue:1 Topics: Adamantane; Antitubercular Agents; Diarylquinolines; Drug Development; Drug Therapy, Combination; Duration of Therapy; Ethambutol; Ethylenediamines; Humans; Isoniazid; Macrolides; Medication Adherence; Nitroimidazoles; Oxazolidinones; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant	2019
Safety of cycloserine and terizidone for the treatment of drug-resistant tuberculosis: a meta-analysis. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2013, Volume: 17, Issue:10 Topics: Antibiotics, Antitubercular; Central Nervous System Diseases; Cycloserine; Humans; Isoxazoles; Mental Disorders; Oxazolidinones; Tuberculosis, Multidrug-Resistant	2013
WHO group 5 drugs and difficult multidrug-resistant tuberculosis: a systematic review with cohort analysis and meta-analysis. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:9 Topics: Acetamides; Adult; Antitubercular Agents; beta-Lactams; Clofazimine; Cohort Studies; Databases, Bibliographic; Female; Fluoroquinolones; Humans; Isoniazid; Linezolid; Macrolides; Male; Oxazolidinones; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2013
[The analysis of clinical data about the treatment of linezolid against tuberculosis]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2013, Volume: 36, Issue:8 Topics: Acetamides; Animals; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Retrospective Studies; Tuberculosis, Multidrug-Resistant	2013
Linezolid for the treatment of drug-resistant tuberculosis in children: a review and recommendations. Tuberculosis (Edinburgh, Scotland), 2014, Volume: 94, Issue:2 Topics: Acetamides; Antitubercular Agents; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Humans; Linezolid; Oxazolidinones; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2014
Tuberculosis: clinical trials and new drug regimens. Current opinion in pulmonary medicine, 2014, Volume: 20, Issue:3 Topics: Acetamides; Adamantane; Antitubercular Agents; Clinical Trials as Topic; Diarylquinolines; Drug Administration Schedule; Drug Design; Ethylenediamines; Female; Fluoroquinolones; Humans; Levofloxacin; Linezolid; Male; Moxifloxacin; Nitroimidazoles; Oxazoles; Oxazolidinones; Spiro Compounds; Thiazines; Tuberculosis; Tuberculosis, Multidrug-Resistant	2014
Novel drugs against tuberculosis: a clinician's perspective. The European respiratory journal, 2015, Volume: 45, Issue:4 Topics: Adamantane; Antitubercular Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Diarylquinolines; Drug Therapy, Combination; Ethylenediamines; Extensively Drug-Resistant Tuberculosis; Female; Follow-Up Studies; Humans; Male; Nitroimidazoles; Oxazoles; Oxazolidinones; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2015
Efficacy and safety of World Health Organization group 5 drugs for multidrug-resistant tuberculosis treatment. The European respiratory journal, 2015, Volume: 46, Issue:5 Topics: Amoxicillin; Antitubercular Agents; Azithromycin; Cilastatin; Clarithromycin; Clavulanic Acid; HIV Infections; Humans; Imipenem; Isoxazoles; Macrolides; Meropenem; Mycobacterium tuberculosis; Oxazolidinones; Randomized Controlled Trials as Topic; Thienamycins; Thioridazine; Treatment Outcome; Tuberculosis, Multidrug-Resistant; World Health Organization	2015
Group 5 drugs for multidrug-resistant tuberculosis: individual patient data meta-analysis. The European respiratory journal, 2017, Volume: 49, Issue:1 Topics: Adult; Amoxicillin; Antitubercular Agents; Clofazimine; Cohort Studies; Drug Therapy, Combination; Female; Humans; Isoxazoles; Linezolid; Logistic Models; Macrolides; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Oxazolidinones; Thioacetazone; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult	2017
Linezolid for the treatment of complicated drug-resistant tuberculosis: a systematic review and meta-analysis. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2012, Volume: 16, Issue:4 Topics: Acetamides; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Oxazolidinones; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2012
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis. The European respiratory journal, 2012, Volume: 40, Issue:6 Topics: Acetamides; Adolescent; Adult; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Patient Safety; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2012

Trials

7 trial(s) available for oxazolidin-2-one and Tuberculosis, Drug-Resistant

Article	Year
Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients. The European respiratory journal, 2013, Volume: 42, Issue:6 Topics: Acetamides; Adult; Aged; Antitubercular Agents; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clarithromycin; Drug Interactions; Drug Monitoring; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Prospective Studies; Tuberculosis, Multidrug-Resistant; Young Adult	2013
Clinical validation of the analysis of linezolid and clarithromycin in oral fluid of patients with multidrug-resistant tuberculosis. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:8 Topics: Acetamides; Adult; Antitubercular Agents; Area Under Curve; Clarithromycin; Confidence Intervals; Drug Monitoring; Female; Humans; Linezolid; Male; Metabolic Clearance Rate; Oxazolidinones; Prospective Studies; Saliva; Tuberculosis, Multidrug-Resistant; Young Adult	2013
[Rezonizat and cycloserine in complex therapy of drug resistant tuberculosis (comparative studies)]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2008, Volume: 53, Issue:11-12 Topics: Adult; Antibiotics, Antitubercular; Cycloserine; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Middle Aged; Oxazolidinones; Tuberculosis, Multidrug-Resistant; Young Adult	2008
Limited sampling strategies for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis. Therapeutic drug monitoring, 2010, Volume: 32, Issue:1 Topics: Acetamides; Adult; Anti-Infective Agents; Area Under Curve; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Linezolid; Oxazolidinones; Prospective Studies; Tandem Mass Spectrometry; Tuberculosis, Multidrug-Resistant; Young Adult	2010
Comparison of the pharmacokinetics of two dosage regimens of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patients. Clinical pharmacokinetics, 2010, Volume: 49, Issue:8 Topics: Acetamides; Adult; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Female; Humans; Linezolid; Male; Oxazolidinones; Tuberculosis, Multidrug-Resistant	2010
Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:6 Topics: Antitubercular Agents; Clarithromycin; Cycloserine; Dapsone; Diarylquinolines; Erythromycin; Female; Humans; Isoxazoles; Male; Ofloxacin; Oxazolidinones; Quinolines; Tuberculosis, Multidrug-Resistant	2012
Lessons from a randomised clinical trial for multidrug-resistant tuberculosis. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2012, Volume: 16, Issue:12 Topics: Acetamides; Antitubercular Agents; Directly Observed Therapy; Double-Blind Method; Drug Monitoring; Female; Humans; Linezolid; Male; Mycobacterium tuberculosis; Oxazolidinones; Patient Dropouts; Pilot Projects; Research Design; South Africa; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2012

Other Studies

78 other study(ies) available for oxazolidin-2-one and Tuberculosis, Drug-Resistant

Article	Year
Prospects of contezolid (MRX-I) against multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis. Drug discoveries & therapeutics, 2022, May-17, Volume: 16, Issue:2 Topics: Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Pyridones; Tuberculosis, Multidrug-Resistant	2022
In vitro activity of tedizolid and linezolid against multidrug-resistant Mycobacterium tuberculosis: a comparative study using microdilution broth assay and genomics. Diagnostic microbiology and infectious disease, 2022, Volume: 103, Issue:3 Topics: Anti-Bacterial Agents; Genomics; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Tetrazoles; Tuberculosis, Multidrug-Resistant	2022
Next-Generation Diarylquinolines Improve Sterilizing Activity of Regimens with Pretomanid and the Novel Oxazolidinone TBI-223 in a Mouse Tuberculosis Model. Antimicrobial agents and chemotherapy, 2023, 04-18, Volume: 67, Issue:4 Topics: Animals; Antitubercular Agents; Diarylquinolines; Linezolid; Mice; Nitroimidazoles; Oxazolidinones; Tuberculosis; Tuberculosis, Multidrug-Resistant	2023
Synergistic Activity of Nitroimidazole-Oxazolidinone Conjugates against Anaerobic Bacteria. Molecules (Basel, Switzerland), 2020, May-22, Volume: 25, Issue:10 Topics: Antitubercular Agents; Bacteria, Anaerobic; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Linezolid; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones; Tuberculosis, Multidrug-Resistant	2020
Discovery of a Conformationally Constrained Oxazolidinone with Improved Safety and Efficacy Profiles for the Treatment of Multidrug-Resistant Tuberculosis. Journal of medicinal chemistry, 2020, 09-10, Volume: 63, Issue:17 Topics: Animals; Chlorocebus aethiops; Drug Design; Female; Hep G2 Cells; Humans; Mice; Microbial Sensitivity Tests; Molecular Conformation; Mycobacterium tuberculosis; Oxazolidinones; Safety; Tuberculosis, Multidrug-Resistant; Vero Cells	2020
Treatment Outcomes and Adverse Drug Effects of Ethambutol, Cycloserine, and Terizidone for the Treatment of Multidrug-Resistant Tuberculosis in South Africa. Antimicrobial agents and chemotherapy, 2020, 12-16, Volume: 65, Issue:1 Topics: Adult; Antitubercular Agents; Cycloserine; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Humans; Isoxazoles; Oxazolidinones; Pharmaceutical Preparations; South Africa; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2020
Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021, Volume: 105 Topics: Adult; Antibiotics, Antitubercular; Cycloserine; Depression; Female; HIV Infections; Humans; Incidence; Isoxazoles; Male; Middle Aged; Oxazolidinones; Peripheral Nervous System Diseases; Prospective Studies; Psychoses, Substance-Induced; Risk Factors; Tuberculosis, Multidrug-Resistant	2021
Hematological side effect analysis of linezolid in MDR-TB patients with individual therapy. Journal of basic and clinical physiology and pharmacology, 2021, Jun-25, Volume: 32, Issue:4 Topics: Acetamides; Anemia; Antitubercular Agents; Drug-Related Side Effects and Adverse Reactions; Humans; Linezolid; Oxazolidinones; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2021
Examination of bedaquiline- and linezolid-resistant Mycobacterium tuberculosis isolates from the Moscow region. The Journal of antimicrobial chemotherapy, 2017, 07-01, Volume: 72, Issue:7 Topics: Acetamides; Antitubercular Agents; Diarylquinolines; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Moscow; Mutation; Mycobacterium tuberculosis; Oxazolidinones; Prospective Studies; Ribosomal Protein L3; Tuberculosis, Multidrug-Resistant	2017
Making optimal use of available anti-tuberculosis drugs: first steps to investigate terizidone. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2018, 01-01, Volume: 22, Issue:1 Topics: Antitubercular Agents; Cycloserine; Humans; Isoxazoles; Oxazolidinones; Tuberculosis; Tuberculosis, Multidrug-Resistant	2018
Steady state pharmacokinetics of cycloserine in patients on terizidone for multidrug-resistant tuberculosis. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2018, 01-01, Volume: 22, Issue:1 Topics: Adult; Antitubercular Agents; Area Under Curve; Chromatography, Liquid; Cycloserine; Female; HIV Infections; Humans; Isoxazoles; Male; Middle Aged; Oxazolidinones; Prospective Studies; Regression Analysis; South Africa; Tandem Mass Spectrometry; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2018
Improved Treatment Outcomes With Bedaquiline When Substituted for Second-line Injectable Agents in Multidrug-resistant Tuberculosis: A Retrospective Cohort Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 04-24, Volume: 68, Issue:9 Topics: Adult; Antitubercular Agents; Coinfection; Diarylquinolines; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Female; HIV; HIV Infections; Humans; Isoniazid; Isoxazoles; Levofloxacin; Male; Mycobacterium tuberculosis; Oxazolidinones; Pyrazinamide; Retrospective Studies; South Africa; Survival Analysis; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2019
Susceptibility testing of extensively drug-resistant and pre-extensively drug-resistant Mycobacterium tuberculosis against levofloxacin, linezolid, and amoxicillin-clavulanate. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:6 Topics: Acetamides; Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Humans; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Oxazolidinones; Pakistan; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2013
Serious treatment related adverse drug reactions amongst anti-retroviral naïve MDR-TB patients. PloS one, 2013, Volume: 8, Issue:4 Topics: Adult; Antitubercular Agents; Coinfection; Cycloserine; Drug Resistance, Multiple, Bacterial; Female; Hearing Loss; HIV Infections; Humans; Isoxazoles; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Oxazolidinones; Prospective Studies; Psychoses, Substance-Induced; South Africa; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2013
Can intermittent dosing optimize prolonged linezolid treatment of difficult multidrug-resistant tuberculosis? Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:7 Topics: Acetamides; Adult; Antitubercular Agents; Drug Administration Schedule; Female; Humans; Linezolid; Male; Middle Aged; Mycobacterium tuberculosis; Oxazolidinones; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult	2013
Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence. The European respiratory journal, 2013, Volume: 42, Issue:1 Topics: Acetamides; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Female; Humans; Male; Oxazolidinones; Tuberculosis, Multidrug-Resistant	2013
Filgrastim therapy in a child with neutropenia induced by linezolid. International journal of clinical pharmacy, 2013, Volume: 35, Issue:4 Topics: Acetamides; Antitubercular Agents; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Infant; Leukocyte Count; Linezolid; Male; Neutropenia; Off-Label Use; Oxazolidinones; Recombinant Proteins; Severity of Illness Index; Time Factors; Tuberculosis, Multidrug-Resistant	2013
Clinical experience of using clofazimine to treat multidrug-resistant tuberculosis [Correspondence]. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2013, Volume: 17, Issue:9 Topics: Acetamides; Adult; Aged; Antitubercular Agents; Clofazimine; Drug Therapy, Combination; Female; Humans; Linezolid; Logistic Models; Male; Middle Aged; Odds Ratio; Oxazolidinones; Risk Factors; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult	2013
Activity of linezolid-containing regimens against multidrug-resistant tuberculosis in mice. International journal of antimicrobial agents, 2014, Volume: 43, Issue:2 Topics: Acetamides; Animals; Antitubercular Agents; Bacterial Load; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Humans; Interferon-gamma; Interleukin-10; Linezolid; Lung; Male; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Oxazolidinones; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2014
Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment? The European respiratory journal, 2013, Volume: 42, Issue:6 Topics: Acetamides; Antitubercular Agents; Clarithromycin; Female; Humans; Linezolid; Male; Oxazolidinones; Tuberculosis, Multidrug-Resistant	2013
Outcomes of MDR/XDR-TB patients treated with linezolid: experience in Thailand. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2013, Volume: 96, Issue:10 Topics: Acetamides; Adult; Anti-Infective Agents; Antitubercular Agents; Capreomycin; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Humans; Linezolid; Male; Middle Aged; Off-Label Use; Oxazolidinones; Retrospective Studies; Thailand; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2013
Prevalence and incidence of symmetrical symptomatic peripheral neuropathy in patients with multidrug-resistant TB. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2013, Oct-11, Volume: 104, Issue:1 Topics: Humans; Incidence; Isoniazid; Isoxazoles; Oxazolidinones; Peripheral Nervous System Diseases; Prevalence; Tuberculosis, Multidrug-Resistant	2013
Optic neuropathy secondary to Linezolid for multidrug-resistant mycobacterial spinal tuberculosis. Ocular immunology and inflammation, 2015, Volume: 23, Issue:1 Topics: Acetamides; Anti-Infective Agents; Humans; Linezolid; Male; Optic Nerve Diseases; Oxazolidinones; Tuberculosis, Multidrug-Resistant; Tuberculosis, Spinal; Young Adult	2015
Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China. International journal of antimicrobial agents, 2014, Volume: 43, Issue:3 Topics: Acetamides; Antitubercular Agents; China; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Linezolid; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Mutation; Mycobacterium tuberculosis; Oxazolidinones; Prevalence; RNA, Ribosomal, 23S; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant	2014
Treatment of multidrug-resistant and extensively drug-resistant tuberculosis in adolescent patients. The Pediatric infectious disease journal, 2014, Volume: 33, Issue:6 Topics: Acetamides; Adolescent; Antitubercular Agents; Child; Extensively Drug-Resistant Tuberculosis; Female; Humans; Linezolid; Male; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis, Multidrug-Resistant	2014
In vitro synergy between linezolid and clarithromycin against Mycobacterium tuberculosis. The European respiratory journal, 2014, Volume: 44, Issue:3 Topics: Acetamides; Anti-Bacterial Agents; Biological Specimen Banks; Clarithromycin; Drug Resistance, Bacterial; Drug Synergism; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis, Multidrug-Resistant	2014
Linezolid in the treatment of drug-resistant tuberculosis: the way forward? The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2014, Volume: 18, Issue:6 Topics: Acetamides; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Mycobacterium tuberculosis; Oxazolidinones; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2014
Second-line drug susceptibilities of multidrug-resistant tuberculosis strains isolated in Thailand: an update. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2014, Volume: 18, Issue:8 Topics: Acetamides; Aminoglycosides; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Thailand; Tuberculosis, Multidrug-Resistant	2014
Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains. The European respiratory journal, 2015, Volume: 45, Issue:1 Topics: Acetamides; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Female; Humans; Male; Oxazolidinones; Tuberculosis, Multidrug-Resistant	2015
Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains. The European respiratory journal, 2015, Volume: 45, Issue:1 Topics: Acetamides; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Female; Humans; Male; Oxazolidinones; Tuberculosis, Multidrug-Resistant	2015
In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis from Shenyang, north of China. Indian journal of medical microbiology, 2015, Volume: 33 Suppl Topics: Acetamides; Anti-Bacterial Agents; China; Drug Resistance, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis; Tuberculosis, Multidrug-Resistant	2015
[Evaluation of second-line antituberculosis drug susceptibilities of multidrug-resistant Mycobacterium tuberculosis complex isolates by E-test method]. Mikrobiyoloji bulteni, 2015, Volume: 49, Issue:1 Topics: Acetamides; Antitubercular Agents; Culture Media; Drug Resistance, Multiple, Bacterial; Ethionamide; Humans; Kanamycin; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Oxazolidinones; Reagent Strips; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2015
Antimycobacterial activity of linezolid against multidrug-resistant and extensively drug-resistant strains of Mycobacterium tuberculosis in Iran. International journal of antimicrobial agents, 2015, Volume: 45, Issue:6 Topics: Acetamides; Anti-Infective Agents; Antitubercular Agents; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Humans; Molecular Typing; Mycobacterium bovis; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis, Multidrug-Resistant	2015
TB: the tap's down a notch – but the water's polluted. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2014, Volume: 104, Issue:8 Topics: Acetamides; Compassionate Use Trials; Congresses as Topic; Diarylquinolines; Drug Resistance, Multiple; Guidelines as Topic; Humans; Linezolid; Mycobacterium tuberculosis; Oxazolidinones; South Africa; Tuberculosis; Tuberculosis Vaccines; Tuberculosis, Multidrug-Resistant; Ventilation	2014
Linezolid for multidrug-resistant tuberculosis: How should we approach it? Enfermedades infecciosas y microbiologia clinica, 2016, Volume: 34, Issue:2 Topics: Acetamides; Antitubercular Agents; Humans; Linezolid; Mycobacterium tuberculosis; Oxazolidinones; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2016
Linezolid for Treating Tuberculosis: A Delicate Balancing Act. EBioMedicine, 2015, Volume: 2, Issue:11 Topics: Acetamides; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Mycobacterium tuberculosis; Oxazolidinones; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant	2015
Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China. The European respiratory journal, 2016, Volume: 47, Issue:5 Topics: Antitubercular Agents; China; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Oxazolidinones; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2016
Case series report of a linezolid-containing regimen for extensively drug-resistant tuberculosis. Chest, 2008, Volume: 134, Issue:1 Topics: Acetamides; Adult; Anti-Infective Agents; Child; Dose-Response Relationship, Drug; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Tuberculosis, Multidrug-Resistant	2008
Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis. International journal of antimicrobial agents, 2009, Volume: 33, Issue:1 Topics: Acetamides; Adult; Anti-Infective Agents; Culture Media; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Female; Humans; Korea; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Oxazolidinones; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult	2009
In vitro activity of linezolid against multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant (XDR)-TB isolates. International journal of antimicrobial agents, 2009, Volume: 33, Issue:2 Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Female; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis, Multidrug-Resistant; Young Adult	2009
Multidrug- and extensively drug-resistant tuberculosis, Germany. Emerging infectious diseases, 2008, Volume: 14, Issue:11 Topics: Acetamides; Adult; Antitubercular Agents; Cohort Studies; Drug Resistance, Multiple, Bacterial; Emigrants and Immigrants; Extensively Drug-Resistant Tuberculosis; Female; Germany; Humans; Linezolid; Male; Mycobacterium tuberculosis; Oxazolidinones; Retrospective Studies; Risk Factors; Sentinel Surveillance; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2008
[A hope for multidrug-resistant tuberculosis?]. Revue medicale suisse, 2008, Oct-15, Volume: 4, Issue:175 Topics: Acetamides; Anti-Infective Agents; Humans; Linezolid; Oxazolidinones; Tuberculosis, Multidrug-Resistant	2008
How should we treat "difficult" multidrug-resistant tuberculosis? Chest, 2009, Volume: 135, Issue:2 Topics: Acetamides; Adult; Anti-Infective Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Linezolid; Male; Maximum Tolerated Dose; Oxazolidinones; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2009
A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis. The European respiratory journal, 2009, Volume: 34, Issue:2 Topics: Acetamides; Anti-Infective Agents; Antitubercular Agents; Cohort Studies; Drug Resistance, Bacterial; Europe; Female; Humans; Linezolid; Male; Odds Ratio; Oxazolidinones; Regression Analysis; Retrospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2009
Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis. The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:2 Topics: Acetamides; Adult; Antitubercular Agents; Female; Humans; Linezolid; Male; Oxazolidinones; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2009
[Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates]. Mikrobiyoloji bulteni, 2009, Volume: 43, Issue:2 Topics: Acetamides; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Isoniazid; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Rifampin; Tuberculosis, Multidrug-Resistant	2009
Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis. The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:4 Topics: Acetamides; Anti-Bacterial Agents; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Oxazolidinones; Tuberculosis, Multidrug-Resistant	2009
Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis. The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:5 Topics: Acetamides; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Oxazolidinones; Tuberculosis, Multidrug-Resistant	2009
Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis--authors' response. The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:5 Topics: Acetamides; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Oxazolidinones; Tuberculosis, Multidrug-Resistant	2009
Fatal lactic acidosis after prolonged linezolid exposure for treatment of multidrug-resistant tuberculosis. European journal of internal medicine, 2009, Volume: 20, Issue:6 Topics: Acetamides; Acidosis, Lactic; Anti-Infective Agents; Fatal Outcome; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Time Factors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2009
Linezolid in the treatment of multidrug-resistant tuberculosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Jan-01, Volume: 50, Issue:1 Topics: Acetamides; Adolescent; Adult; Aged; Antitubercular Agents; Female; Humans; Linezolid; Male; Middle Aged; Mycobacterium tuberculosis; Oxazolidinones; Retrospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2010
What is the optimal dosage of linezolid in treatment of complicated multidrug-resistant tuberculosis? The European respiratory journal, 2009, Volume: 34, Issue:6 Topics: Acetamides; Adult; Diabetes Complications; Drug Administration Schedule; Fluoroquinolones; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Smoking; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2009
Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:4 Topics: Acetamides; Adult; Aged; Antitubercular Agents; Bone Marrow Diseases; Child; Female; Gastrointestinal Diseases; Humans; Incidence; Linezolid; Male; Middle Aged; Nervous System Diseases; New York City; Oxazolidinones; Retrospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult	2010
Increasing pathomorphism of pulmonary tuberculosis: an observational study of slow clinical, microbiological and imaging response of lung tuberculosis to specific treatment. Which role for linezolid? The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2009, Volume: 13, Issue:4 Topics: Acetamides; Adult; Antitubercular Agents; Drug Administration Schedule; Female; Humans; Linezolid; Male; Middle Aged; Mycobacterium tuberculosis; Oxazolidinones; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2009
Two pediatric cases of multidrug-resistant tuberculosis treated with linezolid and moxifloxacin. Pediatrics, 2010, Volume: 126, Issue:5 Topics: Acetamides; Antitubercular Agents; Aza Compounds; Child, Preschool; Emigrants and Immigrants; Female; Fluoroquinolones; Follow-Up Studies; Humans; Infant; Italy; Linezolid; Male; Microbial Sensitivity Tests; Moldova; Moxifloxacin; Oxazolidinones; Quinolines; Romania; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2010
Terizidone. The Journal of the Association of Physicians of India, 2010, Volume: 58 Topics: Antitubercular Agents; Humans; Isoxazoles; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis; Tuberculosis, Multidrug-Resistant	2010
Susceptibility of clinical Mycobacterium tuberculosis isolates to a potentially less toxic derivate of linezolid, PNU-100480. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:3 Topics: Acetamides; Antitubercular Agents; Ethambutol; Isoniazid; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant	2011
Interaction between linezolid and Mycobacterium tuberculosis in an experimental in vitro model. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2011, Volume: 119, Issue:4-5 Topics: Acetamides; Antitubercular Agents; Drug Resistance, Bacterial; Genes, Bacterial; Humans; In Vitro Techniques; Linezolid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis, Multidrug-Resistant	2011
Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:6 Topics: Acetamides; Adult; Antitubercular Agents; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Retrospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2012
Sterilizing activities of novel combinations lacking first- and second-line drugs in a murine model of tuberculosis. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:6 Topics: Animals; Antitubercular Agents; Drug Therapy, Combination; Female; Isoniazid; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant	2012
Comment on: daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:8 Topics: Acetamides; Antitubercular Agents; Female; Humans; Male; Oxazolidinones; Tuberculosis, Multidrug-Resistant	2012
In vitro activity of linezolid against clinical isolates of Mycobacterium tuberculosis, including multidrug-resistant and extensively drug-resistant strains from Beijing, China. Japanese journal of infectious diseases, 2012, Volume: 65, Issue:3 Topics: Acetamides; Antitubercular Agents; China; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis, Multidrug-Resistant	2012
Linezolid in the treatment of MDR-TB: a retrospective clinical study. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2012, Volume: 16, Issue:3 Topics: Acetamides; Adult; Aged; Antitubercular Agents; China; Dose-Response Relationship, Drug; Female; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Oxazolidinones; Retrospective Studies; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult	2012
Linezolid for multidrug-resistant tuberculosis. The Lancet. Infectious diseases, 2012, Volume: 12, Issue:7 Topics: Acetamides; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Oxazolidinones; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2012
Dried blood spot analysis for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11 Topics: Acetamides; Adult; Antitubercular Agents; Chromatography, High Pressure Liquid; Dried Blood Spot Testing; Drug Monitoring; Female; Humans; Linezolid; Male; Mycobacterium tuberculosis; Oxazolidinones; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Tuberculosis, Multidrug-Resistant	2012
Efficacy and safety of meropenem-clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB. The European respiratory journal, 2013, Volume: 41, Issue:6 Topics: Acetamides; Adult; Antitubercular Agents; Case-Control Studies; Clavulanic Acid; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Humans; Linezolid; Male; Meropenem; Middle Aged; Oxazolidinones; Thienamycins; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2013
Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2012, Volume: 16, Issue:12 Topics: Acetamides; Adolescent; Age Factors; Anti-HIV Agents; Antitubercular Agents; Child; Child, Preschool; Coinfection; Cost Savings; Drug Costs; Drug Interactions; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; HIV Infections; Humans; Infant; Linezolid; Male; Mycobacterium tuberculosis; Oxazolidinones; Retrospective Studies; South Africa; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2012
Challenging trials. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2012, Volume: 16, Issue:12 Topics: Acetamides; Antitubercular Agents; Female; Humans; Linezolid; Male; Oxazolidinones; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2012
Linezolid for multidrug-resistant tuberculosis - authors' reply. The Lancet. Infectious diseases, 2013, Volume: 13, Issue:1 Topics: Acetamides; Antitubercular Agents; Humans; Oxazolidinones; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2013
Linezolid for multidrug-resistant tuberculosis. The Lancet. Infectious diseases, 2013, Volume: 13, Issue:1 Topics: Acetamides; Antitubercular Agents; Humans; Oxazolidinones; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2013
In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:1 Topics: Acetamides; Antitubercular Agents; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis, Multidrug-Resistant	2003
Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)--a report of ten cases. The Journal of infection, 2006, Volume: 52, Issue:2 Topics: Acetamides; Adult; Anemia; Anti-Infective Agents; Bone Marrow Diseases; Drug Therapy, Combination; Female; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Peripheral Nervous System Diseases; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2006
Linezolid for the treatment of multidrug-resistant tuberculosis. The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:1 Topics: Acetamides; Adult; Female; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Tuberculosis, Multidrug-Resistant	2005
[Peripheral and optic neuropathy associated to linezolod in multidrug resistant Mycobacterium bovis infection]. Medicina clinica, 2005, May-28, Volume: 124, Issue:20 Topics: Acetamides; Aged; Anti-Infective Agents; Humans; Linezolid; Male; Mycobacterium bovis; Optic Nerve Diseases; Oxazolidinones; Peripheral Nervous System Diseases; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2005
First linezolid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4 Topics: Acetamides; Antitubercular Agents; Drug Resistance, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis, Multidrug-Resistant	2007
Linezolid in the treatment of 'difficult' multidrug-resistant tuberculosis. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2008, Volume: 12, Issue:3 Topics: Acetamides; Anti-Infective Agents; Humans; Linezolid; Oxazolidinones; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Spinal	2008
In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis complex isolated in Taiwan over 10 years. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6 Topics: Acetamides; Antitubercular Agents; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Taiwan; Tuberculosis; Tuberculosis, Multidrug-Resistant	2008
[Multiresistant tuberculosis caused by Mycobacterium bovis and human immunodeficiency virus infection. Are there new therapeutic possibilities?]. Enfermedades infecciosas y microbiologia clinica, 2001, Volume: 19, Issue:1 Topics: Acetamides; Adult; AIDS-Related Opportunistic Infections; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Clavulanic Acid; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Isoniazid; Linezolid; Mycobacterium bovis; Oxazolidinones; Thioacetazone; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2001